blonanserin has been researched along with guanfacine in 1 studies
| Studies (blonanserin) | Trials (blonanserin) | Recent Studies (post-2010) (blonanserin) | Studies (guanfacine) | Trials (guanfacine) | Recent Studies (post-2010) (guanfacine) |
|---|---|---|---|---|---|
| 121 | 21 | 93 | 784 | 180 | 273 |
| Protein | Taxonomy | blonanserin (IC50) | guanfacine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.453 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.134 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.249 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 6.447 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.014 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.453 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 2.098 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiuchi, F; Kawabe, K; Ueno, SI | 1 |
1 other study(ies) available for blonanserin and guanfacine
| Article | Year |
|---|---|
Combination treatment with guanfacine extended release and blonanserin for Tourette's syndrome comorbid with attention deficit hyperactivity disorder.
Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Delayed-Action Preparations; Drug Therapy, Combination; Guanfacine; Humans; Male; Piperazines; Piperidines; Tourette Syndrome | 2019 |